Toggle navigation
Logout
Change account settings
EN
DE
ES
FR
A-Z
Beta
About EconBiz
News
Thesaurus (STW)
Academic Skills
Help
EN
DE
ES
FR
My account
Logout
Change account settings
Login
Publications
Events
Your search terms
Search
Search options
All Fields
Title
Exact title
Subject
Author
Institution
ISBN/ISSN
Published in...
Publisher
Open Access only
Advanced
Search history
My EconBiz
Favorites
Loans
Reservations
Fines
You are here:
Home
Search: subject:"Acute lymphoblastic leukaemia"
Narrow search
Narrow search
Year of publication
From:
To:
Subject
All
Acute lymphoblastic leukaemia
2
Asparaginase
2
Cost-effectiveness
2
First line treatment
2
Cost-benefit analysis
1
Cost-effectiveness analysis
1
Gesundheitskosten
1
Großbritannien
1
Health care costs
1
Kosten-Nutzen-Analyse
1
Kosten-Wirksamkeits-Analyse
1
Theorie
1
Theory
1
United Kingdom
1
more ...
less ...
Online availability
All
Free
2
Type of publication
All
Article
2
Type of publication (narrower categories)
All
Article
1
Article in journal
1
Aufsatz in Zeitschrift
1
Language
All
English
2
Author
All
Basu, Subham
2
Hu, Xingdi
2
Lin, Peggy L.
2
Rowntree, Clare
2
Saha, Vaskar
2
Wildman, Kingsley P.
2
Published in...
All
Health Economics Review
1
Health economics review
1
Source
All
ECONIS (ZBW)
1
EconStor
1
Showing
1
-
2
of
2
Sort
relevance
articles prioritized
date (newest first)
date (oldest first)
1
The cost-effectiveness of pegaspargase versus native asparaginase for first-line treatment of
acute
lymphoblastic
leukaemia
: A UK-based cost-utility analysis
Hu, Xingdi
;
Wildman, Kingsley P.
;
Basu, Subham
;
Lin, …
- In:
Health Economics Review
9
(
2019
)
40
,
pp. 1-13
Background: L-asparaginase is a key component of treatment for patients with
acute
lymphoblastic
leukaemia
(ALL) in the …
Persistent link: https://www.econbiz.de/10014489890
Saved in:
2
The cost-effectiveness of pegaspargase versus native asparaginase for first-line treatment of
acute
lymphoblastic
leukaemia
: a UK-based cost-utility analysis
Hu, Xingdi
;
Wildman, Kingsley P.
;
Basu, Subham
;
Lin, …
- In:
Health economics review
9
(
2019
)
40
,
pp. 1-13
Background: L-asparaginase is a key component of treatment for patients with
acute
lymphoblastic
leukaemia
(ALL) in the …
Persistent link: https://www.econbiz.de/10012162665
Saved in:
Results per page
10
25
50
100
250
A service of the
zbw
×
Loading...
